Related Experiment Video
Updated: Jul 17, 2026

Total Protein Extraction and 2-D Gel Electrophoresis Methods for Burkholderia Species
Published on: October 15, 2013
The identification of surface proteins of Burkholderia pseudomallei
Sarah V Harding1, Mitali Sarkar-Tyson, Sophie J Smither
1Dstl, Porton Down, Salisbury, Wiltshire SP4 0JQ, UK. svharding@dstl.gov.uk
Abstract:
Burkholderia pseudomallei, the causative agent of the disease melioidosis is a human pathogen endemic in Northern Australia and South-East Asia. At present there is no available vaccine or effective treatment for this disease. Surface proteins play crucial roles in the host-pathogen interaction and have been exploited as vaccine candidates and diagnostic targets. Therefore, we wished to identify immunogenic surface proteins of B. pseudomallei. To this end we used two proteomic-based approaches in parallel: a biotinylation approach for the detection of surface located proteins identified 35 proteins, while screening with human sera identified 12 immunogenic proteins. Nine of these proteins were identified by both methods indicating that they may be both surface located and immunogenic: these proteins will be evaluated further as vaccine candidates and diagnostic targets.
Insights
Researchers identified nine key surface proteins of Burkholderia pseudomallei, the cause of melioidosis. These proteins are potential targets for developing new vaccines and diagnostics against this dangerous human pathogen.
Area of Science:
- Microbiology
- Immunology
- Proteomics
Background:
- Melioidosis is a serious human disease caused by Burkholderia pseudomallei, endemic in Southeast Asia and Northern Australia.
- Currently, no effective treatments or vaccines exist for melioidosis.
- Surface proteins are critical for host-pathogen interactions and are promising targets for vaccine and diagnostic development.
Purpose of the Study:
- To identify immunogenic surface proteins of Burkholderia pseudomallei.
- To find potential vaccine candidates and diagnostic targets for melioidosis.
Main Methods:
- Employed two parallel proteomic approaches: biotinylation for surface protein detection and human serum screening for immunogenicity.
- Identified 35 surface-located proteins using biotinylation.
- Detected 12 immunogenic proteins through serum screening.
Main Results:
- Nine proteins were identified by both biotinylation and serum screening methods.
- These nine proteins are likely both surface-located and immunogenic.
- This overlap suggests their high potential as targets.
Conclusions:
- Identified nine novel B. pseudomallei surface proteins that are immunogenic.
- These proteins represent promising candidates for future vaccine development and diagnostic tools.
- Further evaluation of these proteins is warranted for melioidosis control.
Related Concept Videos
Rapid Identification of Pathogens
Methods of Classification and Identification

